Search News Archives
Follow us on
Conferences | Events

Media Partners

 

Gallus BioPharmaceuticals Utilises ambr15 Micro Bioreactor To Rapidly Optimise Process Development of Novel Antibodies and Biosimilars

publication date: May 14, 2014
 | 
author/source: TAP Biosystems

TAP Biosystems, (now part of the Sartorius Stedim Biotech Group), is delighted to announce its ambr15 micro bioreactor system is being used at the leading US-based Contract Manufacturing Organisation (CMO), Gallus BioPharmaceuticals, LLC (“Gallus”) to optimise process development and clone selection of novel antibody therapeutics and biosimilars.

TAP biosystems AMBR

Gallus’ scientists are using the ambr15 micro bioreactor in their new, state-of-the-art Process Development facility in St. Louis, Missouri. The system is being used for clone selection programmes to determine which CHO cell lines are stable and produce the highest titre mAbs. They are also using the ambr system to optimise media selection and feed strategies for these mAbs, which are being developed as antibody therapeutics and biosimilars for some of the world’s top pharma and biotech firms.

Matt Caple, Scientific Director of Cell Culture Development at Gallus said: “Our clients want high yielding, pure biotherapeutic antibodies that they can take into clinical trials as quickly as possible. However, they often come to us without any process development history for their mAb clones and we have to ensure we build them a robust process.  We used to do this with multiple shake flask and benchtop scale bioreactor runs - in one media development project we performed 1000 shake flasks runs - however, we knew we couldn’t continue to work at this labour-intensive scale.  So we assessed a number of bioreactor models and concluded that the ambr15 system was the right option for us.”

Caple added: “We have now been working with our ambr15 for six months and, from our comparison studies, have seen the titre results of our mAbs correlate well with those we obtained in 50L bioreactors.  We are currently using ambr15 routinely for our bioprocess characterisation work and are looking at using it for perfusion culture modelling. For us, ambr is ‘game changing’ technology, so much so that we are now running it around the clock and are considering buying a second system.”

Dr Barney Zoro, ambr15 Product Manager at TAP Biosystems stated: "We’re delighted that Gallus has integrated the ambr15 system so seamlessly into their new Process Development facility. Their confidence in the system shows scientists that ambr15 is the proven choice for helping to deliver robust, high-performance cell culture processes, especially where biotech and pharma clients are imposing stringent timelines and product quality targets.”


more about TAP biosystems


more news from sartorius



If you have not logged into the website then please enter your details below.



 

Popular this Month

 

Chromatography in Cannabis Testing

 

New Catalogue of Infectious Disease Antibodies and Antigens

 

Acquisition of B&W Tek takes Metrohm’s Spectroscopy Portfolio to the Next Level

 

Gilson announce the release of the extended mass range VERITY® 1910 MS Detector

 

NanoFCM Opens European Office and Centre of Excellence for Scientific Application Support

 

Hitachi High-Technologies Launches Two New Scanning Electron Microscopes

 

Discovery Park & MedCity to Partner on Prestigious Angels In MedCity Programme

 

Merck Lectureship 2019 Awarded to Susumu Kitagawa

 

BioCity Invests in Carbon Recycling Start-Up, Deep Branch Biotechnology

 

Agilent Announces Unique Portfolio to Advance Immunotherapy

 

 


 

 


 

Can't find what you are looking for?

Search by company or by product


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd